GlassScriptPhysician profile
Sweety Samuel
NPI 1861128407
$6,695.99
in general payments reported to CMS, 2019-2025
23 companies · $3,384 in 2025
The $3,384 reported for 2025 was more than what 98% of Psychiatric/Mental Health (Registered Nurse) providers received nationally (typical 2025 total: $137).
See the full distribution for Psychiatric/Mental Health (Registered Nurse)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $329 · 2024: $2,983 · 2025: $3,384.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,488 · Education: $208.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,488.33 |
| Education | $207.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $646.42 | 2023-2025 | |
| Amgen INC. | $593.86 | 2023-2025 | Otezla |
| Leo Pharma INC. | $593.61 | 2023-2025 | Adbry, Anzupgo |
| Ucb, INC. | $563.53 | 2024-2025 | Bimzelx |
| Regeneron Healthcare Solutions, INC. | $495.54 | 2023-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $487.09 | 2024-2025 | |
| Incyte Corporation | $484.77 | 2024-2025 | Opzelura, Opzelura |
| E.R. Squibb & Sons, L.L.C. | $465.06 | 2023-2025 | Sotyktu |
| Lilly USA, LLC | $449.89 | 2024-2025 | Taltz, Ebglyss |
| Arcutis Biotherapeutics, INC. | $413.46 | 2024-2025 | Zoryve |
| Galderma Laboratories, L.P. | $297.33 | 2024-2025 | Nemluvio, Aklief |
| Pfizer INC. | $261.56 | 2024-2025 | |
| Genzyme Corporation | $240.56 | 2024-2025 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $159.19 | 2025 | Cabtreo, Siliq, Jublia |
| Sun Pharmaceutical Industries INC. | $144.64 | 2024-2025 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $111.76 | 2024-2025 | Hadlima, Vtama |
| Sanofi-Aventis U.S. LLC | $99.00 | 2025 | |
| Dermavant Sciences, INC. | $59.41 | 2023-2024 | Vtama |
| Janssen Biotech, INC. | $57.15 | 2024-2025 | Tremfya, Stelara, Simponi Aria |
| Medimetriks Pharmaceuticals, INC. | $23.25 | 2025 | Clindacin Etz |
| Botanix Sb INC | $18.92 | 2025 | Sofdra |
| Biofrontera INC. | $15.83 | 2025 | |
| Ani Pharmaceuticals, INC. | $14.16 | 2025 | Veregen |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sweety Samuel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.